Am J Epidemiol 2004; 159:882-890.
Copyright © 2004 by the Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker
1 Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
2 Department of Biostatistics, University of Washington, Seattle, WA.
3 Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
A marker strongly associated with outcome (or disease) is often assumed to be effective for classifying persons according to their current or future outcome. However, for this assumption to be true, the associated odds ratio must be of a magnitude rarely seen in epidemiologic studies. In this paper, an illustration of the relation between odds ratios and receiver operating characteristic curves shows, for example, that a marker with an odds ratio of as high as 3 is in fact a very poor classification tool. If a marker identifies 10% of controls as positive (false positives) and has an odds ratio of 3, then it will correctly identify only 25% of cases as positive (true positives). The authors illustrate that a single measure of association such as an odds ratio does not meaningfully describe a marker’s ability to classify subjects. Appropriate statistical methods for assessing and reporting the classification power of a marker are described. In addition, the serious pitfalls of using more traditional methods based on parameters in logistic regression models are illustrated.
biological markers; diagnostic test; logistic regression; odds ratio; ROC curve; screening test
Abbreviations: Abbreviations: FPF, false-positive fraction; ROC, receiver operating characteristic; TPF, true-positive fraction.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. J. Wilson, N. Qureshi, P. Santaguida, J. Little, J. C. Carroll, J. Allanson, and P. Raina Systematic Review: Family History in Risk Assessment for Common Diseases Ann Intern Med, November 2, 2009; (2009) 0000605-200912150-00177v1. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. H. Wise Confronting Social Disparities in Child Health: A Critical Appraisal of Life-Course Science and Research Pediatrics, November 1, 2009; 124(Supplement_3): S203 - S211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Galea, M. Riddle, and G. A Kaplan Causal thinking and complex system approaches in epidemiology Int. J. Epidemiol., October 9, 2009; (2009) dyp296v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. I. Buckley, R. Fu, M. Freeman, K. Rogers, and M. Helfand C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force Ann Intern Med, October 6, 2009; 151(7): 483 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Helfand, D. I. Buckley, M. Freeman, R. Fu, K. Rogers, C. Fleming, and L. L. Humphrey Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force Ann Intern Med, October 6, 2009; 151(7): 496 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Holmstrom, M. Johansson, A. Bergh, U.-H. Stenman, G. Hallmans, and P. Stattin Prostate specific antigen for early detection of prostate cancer: longitudinal study BMJ, September 24, 2009; 339(sep24_1): b3537 - b3537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A Scott Thigh circumference and risk of heart disease and premature death BMJ, September 3, 2009; 339(sep03_2): b3302 - b3302. [Full Text]
|
|
|
|
 |
|
 J. F. Steiner, P. M. Ho, B. L. Beaty, L. M. Dickinson, R. Hanratty, C. Zeng, H. M. Tavel, E. P. Havranek, A. J. Davidson, D. J. Magid, et al. Sociodemographic and Clinical Characteristics Are Not Clinically Useful Predictors of Refill Adherence in Patients With Hypertension Circ Cardiovasc Qual Outcomes, September 1, 2009; 2(5): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Melander, C. Newton-Cheh, P. Almgren, B. Hedblad, G. Berglund, G. Engstrom, M. Persson, J. G. Smith, M. Magnusson, A. Christensson, et al. Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community JAMA, July 1, 2009; 302(1): 49 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hagstrom, P. Hellman, T. E. Larsson, E. Ingelsson, L. Berglund, J. Sundstrom, H. Melhus, C. Held, L. Lind, K. Michaelsson, et al. Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community Circulation, June 2, 2009; 119(21): 2765 - 2771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Hlatky, P. Greenland, D. K. Arnett, C. M. Ballantyne, M. H. Criqui, M. S.V. Elkind, A. S. Go, F. E. Harrell Jr, Y. Hong, B. V. Howard, et al. Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association Circulation, May 5, 2009; 119(17): 2408 - 2416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Pugliese, M. G. M. Hunink, K. Gruszczynska, F. Alberghina, R. Malago, N. van Pelt, N. R. Mollet, F. Cademartiri, A. C. Weustink, W. B. Meijboom, et al. Learning Curve for Coronary CT Angiography: What Constitutes Sufficient Training? Radiology, May 1, 2009; 251(2): 359 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. MacKay, S. M. Haffner, L. E. Wagenknecht, R. B. D'Agostino Jr., and A. J.G. Hanley Prediction of Type 2 Diabetes Using Alternate Anthropometric Measures in a Multi-Ethnic Cohort: The Insulin Resistance Atherosclerosis Study Diabetes Care, May 1, 2009; 32(5): 956 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Hallan, E. Ritz, S. Lydersen, S. Romundstad, K. Kvenild, and S. R. Orth Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD J. Am. Soc. Nephrol., May 1, 2009; 20(5): 1069 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Manduca, M. J. Carston, J. J. Heine, C. G. Scott, V. S. Pankratz, K. R. Brandt, T. A. Sellers, C. M. Vachon, and J. R. Cerhan Texture Features from Mammographic Images and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 837 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shah, J. P Casas, J. A Cooper, I. Tzoulaki, R. Sofat, V. McCormack, L. Smeeth, J. E Deanfield, G. D Lowe, A. Rumley, et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts Int. J. Epidemiol., February 1, 2009; 38(1): 217 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Hingorani, T. Shah, J. P. Casas, S. E. Humphries, and P. J. Talmud C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target? Clin. Chem., February 1, 2009; 55(2): 239 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Nambi, R. C. Hoogeveen, L. Chambless, Y. Hu, H. Bang, J. Coresh, H. Ni, E. Boerwinkle, T. Mosley, R. Sharrett, et al. Lipoprotein-Associated Phospholipase A2 and High-Sensitivity C-Reactive Protein Improve the Stratification of Ischemic Stroke Risk in the Atherosclerosis Risk in Communities (ARIC) Study Stroke, February 1, 2009; 40(2): 376 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Paynter, D. I. Chasman, J. E. Buring, D. Shiffman, N. R. Cook, and P. M. Ridker Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3 Ann Intern Med, January 20, 2009; 150(2): 65 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A Scott Evaluating cardiovascular risk assessment for asymptomatic people BMJ, January 5, 2009; 338(jan05_1): a2844 - a2844. [Full Text]
|
|
|
|
 |
|
 W. Gu and M. S. Pepe Estimating the capacity for improvement in risk prediction with a marker Biostat., January 1, 2009; 10(1): 172 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rambod, C. P Kovesdy, R. Bross, J. D Kopple, and K. Kalantar-Zadeh Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1485 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lee Mistakes in validating the accuracy of a prediction classifier in high-dimensional but small-sample microarray data Statistical Methods in Medical Research, December 1, 2008; 17(6): 635 - 642. [Abstract] [PDF]
|
|
|
|
 |
|
 M. King, C. Walker, G. Levy, C. Bottomley, P. Royston, S. Weich, J. A. Bellon-Saameno, B. Moreno, I. Svab, D. Rotar, et al. Development and Validation of an International Risk Prediction Algorithm for Episodes of Major Depression in General Practice Attendees: The PredictD Study Arch Gen Psychiatry, December 1, 2008; 65(12): 1368 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Koopman, A. G. Mainous III, C. J. Everett, and R. E. Carter Tool to Assess Likelihood of Fasting Glucose ImpairmenT (TAG-IT) Ann. Fam. Med, November 1, 2008; 6(6): 555 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.F. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino Sr, and C. J. O'Donnell C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rambod, C. P. Kovesdy, and K. Kalantar-Zadeh Combined High Serum Ferritin and Low Iron Saturation in Hemodialysis Patients: The Role of Inflammation Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1691 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden American College of Endocrinology Pre-Diabetes Consensus Conference: Part One Diabetes Care, October 1, 2008; 31(10): 2062 - 2069. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M.G. Taylor, D. P. Ankerst, and R. R. Andridge Validation of Biomarker-Based Risk Prediction Models Clin. Cancer Res., October 1, 2008; 14(19): 5977 - 5983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Thomas, G Peat, C Mallen, L Wood, R Lacey, R Duncan, and P Croft Predicting the course of functional limitation among older adults with knee pain: do local signs, symptoms and radiographs add anything to general indicators? Ann Rheum Dis, October 1, 2008; 67(10): 1390 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Lowe, C. Shah, E. Wallace, G. Anderson, P. Paley, M. McIntosh, M. R. Andersen, N. Scholler, L. Bergan, J. Thorpe, et al. Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-Risk for Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2480 - 2487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Gail Discriminatory Accuracy From Single-Nucleotide Polymorphisms in Models to Predict Breast Cancer Risk J Natl Cancer Inst, July 16, 2008; 100(14): 1037 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Castle Invited Commentary: Is Monitoring of Human Papillomavirus Infection for Viral Persistence Ready for Use in Cervical Cancer Screening? Am. J. Epidemiol., July 15, 2008; 168(2): 138 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Janes and M. S. Pepe Adjusting for Covariates in Studies of Diagnostic, Screening, or Prognostic Markers: An Old Concept in a New Setting Am. J. Epidemiol., July 1, 2008; 168(1): 89 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Collette, F. Bonnetain, X. Paoletti, M. Doffoel, O. Bouche, J. L. Raoul, P. Rougier, F. Masskouri, L. Bedenne, and J. C. Barbare Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials Ann. Onc., June 1, 2008; 19(6): 1117 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zethelius, L. Berglund, J. Sundstrom, E. Ingelsson, S. Basu, A. Larsson, P. Venge, and J. Arnlov Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes N. Engl. J. Med., May 15, 2008; 358(20): 2107 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Cai and S. Cheng Robust combination of multiple diagnostic tests for classifying censored event times Biostat., April 1, 2008; 9(2): 216 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Weintraub and G. A. Diamond Predicting Cardiovascular Events with Coronary Calcium Scoring N. Engl. J. Med., March 27, 2008; 358(13): 1394 - 1396. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Tice, S. R. Cummings, R. Smith-Bindman, L. Ichikawa, W. E. Barlow, and K. Kerlikowske Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model Ann Intern Med, March 4, 2008; 148(5): 337 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Coca and C. R. Parikh Urinary Biomarkers for Acute Kidney Injury: Perspectives on Translation Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 481 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Wang New cardiovascular risk factors exist, but are they clinically useful? Eur. Heart J., February 2, 2008; 29(4): 441 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Pepe, Z. Feng, Y. Huang, G. Longton, R. Prentice, I. M. Thompson, and Y. Zheng Integrating the Predictiveness of a Marker with Its Performance as a Classifier Am. J. Epidemiol., February 1, 2008; 167(3): 362 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Cook Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve Clin. Chem., January 1, 2008; 54(1): 17 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Gao, H. Chen, M. A. Schwarzschild, D. B. Glasser, G. Logroscino, E. B. Rimm, and A. Ascherio Erectile Function and Risk of Parkinson's Disease Am. J. Epidemiol., December 15, 2007; 166(12): 1446 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Etzioni, D. P. Ankerst, N. S. Weiss, L. Y. T. Inoue, and I. M. Thompson Is Prostate-Specific Antigen Velocity Useful in Early Detection of Prostate Cancer? A Critical Appraisal of the Evidence J Natl Cancer Inst, October 17, 2007; 99(20): 1510 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. y. Cheng High-Sensitivity C-Reactive Protein and Prediction of Nontraumatic Fractures Arch Intern Med, October 8, 2007; 167(18): 2007 - 2007. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Meuwese, E. S.G. Stroes, S. L. Hazen, J. N. van Miert, J. A. Kuivenhoven, R. G. Schaub, N. J. Wareham, R. Luben, J. J.P. Kastelein, K.-T. Khaw, et al. Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals: The EPIC-Norfolk Prospective Population Study J. Am. Coll. Cardiol., July 10, 2007; 50(2): 159 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Ridker C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2129 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. van der Steeg, S. M. Boekholdt, E. A. Stein, K. El-Harchaoui, E. S.G. Stroes, M. S. Sandhu, N. J. Wareham, J. W. Jukema, R. Luben, A. H. Zwinderman, et al. Role of the Apolipoprotein B-Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case-Control Analysis in EPIC-Norfolk Ann Intern Med, May 1, 2007; 146(9): 640 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Berkwits and E. Guallar Risk Factors, Risk Prediction, and the Apolipoprotein B-Apolipoprotein A-I Ratio Ann Intern Med, May 1, 2007; 146(9): 677 - 679. [Full Text] [PDF]
|
|
|
|
|
|
M. J Khoury, J. Little, M. Gwinn, and J. P. Ioannidis On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies Int. J. Epidemiol., April 1, 2007; 36(2): 439 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Cook Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction Circulation, February 20, 2007; 115(7): 928 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Hillier, K. L. Stone, D. C. Bauer, J. H. Rizzo, K. L. Pedula, J. A. Cauley, K. E. Ensrud, M. C. Hochberg, and S. R. Cummings Evaluating the Value of Repeat Bone Mineral Density Measurement and Prediction of Fractures in Older Women: The Study of Osteoporotic Fractures Arch Intern Med, January 22, 2007; 167(2): 155 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dupuy and R. M. Simon Critical Review of Published Microarray Studies for Cancer Outcome and Guidelines on Statistical Analysis and Reporting J Natl Cancer Inst, January 17, 2007; 99(2): 147 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lorenzo, K. Williams, K. J. Hunt, and S. M. Haffner The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes Diabetes Care, January 1, 2007; 30(1): 8 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Ware The Limitations of Risk Factors as Prognostic Tools N. Engl. J. Med., December 21, 2006; 355(25): 2615 - 2617. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wang, P. Gona, M. G. Larson, G. H. Tofler, D. Levy, C. Newton-Cheh, P. F. Jacques, N. Rifai, J. Selhub, S. J. Robins, et al. Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death N. Engl. J. Med., December 21, 2006; 355(25): 2631 - 2639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Gerber, J. P. McConnell, A. S. Jaffe, S. A. Weston, J. M. Killian, and V. L. Roger Lipoprotein-Associated Phospholipase A2 and Prognosis After Myocardial Infarction in the Community Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2517 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Bos, C. M. A. Schipper, P. J. Koudstaal, J. C.M. Witteman, A. Hofman, and M. M.B. Breteler High Serum C-Reactive Protein Level Is Not an Independent Predictor for Stroke: The Rotterdam Study Circulation, October 10, 2006; 114(15): 1591 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Simon Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling. J Natl Cancer Inst, September 6, 2006; 98(17): 1169 - 1171. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Simon, G. Chironi, and J. Levenson Performance of Subclinical Arterial Disease Detection as a Screening Test for Coronary Heart Disease Hypertension, September 1, 2006; 48(3): 392 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Thompson, C. Chi, D. P. Ankerst, P. J. Goodman, C. M. Tangen, S. M. Lippman, M. S. Lucia, H. L. Parnes, and C. A. Coltman Jr. Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer. J Natl Cancer Inst, August 16, 2006; 98(16): 1128 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kistorp Risk Stratification in Secondary Prevention: Advances in Multimarker Profiles, or Back to Basics? Circulation, July 18, 2006; 114(3): 184 - 186. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Lloyd-Jones, K. Liu, L. Tian, and P. Greenland Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease Ann Intern Med, July 4, 2006; 145(1): 35 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. F. Wilson, M. Pencina, R. B. D'Agostino Sr, and C. J. O'Donnell C-Reactive Protein and Cardiovascular Risk in the Framingham Study--Reply Arch Intern Med, June 26, 2006; 166(12): 1328 - 1328. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF]
|
|
|
|
|
|
I. M. Thompson, D. P. Ankerst, C. Chi, P. J. Goodman, C. M. Tangen, M. S. Lucia, Z. Feng, H. L. Parnes, and C. A. Coltman Jr. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst, April 19, 2006; 98(8): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Alonzo Standards for Reporting Prognostic Tumor Marker Studies J. Clin. Oncol., December 20, 2005; 23(36): 9053 - 9054. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ma and J. Huang Regularized ROC method for disease classification and biomarker selection with microarray data Bioinformatics, December 15, 2005; 21(24): 4356 - 4362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, A. J. Karter, K. Williams, A. Festa, R. B. D'Agostino Jr, L. E. Wagenknecht, and S. M. Haffner Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Circulation, December 13, 2005; 112(24): 3713 - 3721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pischon, C. J. Girman, F. M. Sacks, N. Rifai, M. J. Stampfer, and E. B. Rimm Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men Circulation, November 29, 2005; 112(22): 3375 - 3383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Greenland and P. G. O'Malley When Is a New Prediction Marker Useful?: A Consideration of Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein for Stroke Risk Arch Intern Med, November 28, 2005; 165(21): 2454 - 2456. [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Rutter, J. B. Meigs, L. M. Sullivan, R. B. D'Agostino Sr, and P. W. Wilson Insulin Resistance, the Metabolic Syndrome, and Incident Cardiovascular Events in the Framingham Offspring Study Diabetes, November 1, 2005; 54(11): 3252 - 3257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, C. Sempos, R. P. Donahue, J. Dorn, M. Trevisan, and S. M. Grundy Joint Distribution of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction Among Individuals With and Without Diabetes Diabetes Care, August 1, 2005; 28(8): 1916 - 1921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W-Q Wei, C C Abnet, N Lu, M J Roth, G-Q Wang, B A Dye, Z-W Dong, P R Taylor, P Albert, Y-L Qiao, et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China Gut, June 1, 2005; 54(6): 759 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Shlipak, L. F. Fried, M. Cushman, T. A. Manolio, D. Peterson, C. Stehman-Breen, A. Bleyer, A. Newman, D. Siscovick, and B. Psaty Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors JAMA, April 13, 2005; 293(14): 1737 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Lloyd-Jones and P. Greenland Letter Regarding Article by Ridker et al, "Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?" Circulation, December 14, 2004; 110(24): e532 - e532. [Full Text] [PDF]
|
|
|
|
|
|
M. P. Stern, K. Williams, C. Gonzalez-Villalpando, K. J. Hunt, and S. M. Haffner Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease? Diabetes Care, November 1, 2004; 27(11): 2676 - 2681. [Abstract] [Full Text] [PDF]
|
|